1. Home
  2. CDXS vs EUDA Comparison

CDXS vs EUDA Comparison

Compare CDXS & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • EUDA
  • Stock Information
  • Founded
  • CDXS 2002
  • EUDA 2021
  • Country
  • CDXS United States
  • EUDA Singapore
  • Employees
  • CDXS N/A
  • EUDA N/A
  • Industry
  • CDXS Major Chemicals
  • EUDA Blank Checks
  • Sector
  • CDXS Industrials
  • EUDA Finance
  • Exchange
  • CDXS Nasdaq
  • EUDA Nasdaq
  • Market Cap
  • CDXS 176.4M
  • EUDA 152.3M
  • IPO Year
  • CDXS 2010
  • EUDA N/A
  • Fundamental
  • Price
  • CDXS $2.47
  • EUDA $3.94
  • Analyst Decision
  • CDXS Buy
  • EUDA
  • Analyst Count
  • CDXS 2
  • EUDA 0
  • Target Price
  • CDXS $11.00
  • EUDA N/A
  • AVG Volume (30 Days)
  • CDXS 532.0K
  • EUDA 105.8K
  • Earning Date
  • CDXS 05-14-2025
  • EUDA 01-01-0001
  • Dividend Yield
  • CDXS N/A
  • EUDA N/A
  • EPS Growth
  • CDXS N/A
  • EUDA N/A
  • EPS
  • CDXS N/A
  • EUDA N/A
  • Revenue
  • CDXS $59,345,000.00
  • EUDA $4,011,005.00
  • Revenue This Year
  • CDXS $12.62
  • EUDA $212.19
  • Revenue Next Year
  • CDXS $22.11
  • EUDA $254.35
  • P/E Ratio
  • CDXS N/A
  • EUDA N/A
  • Revenue Growth
  • CDXS N/A
  • EUDA 8.22
  • 52 Week Low
  • CDXS $1.90
  • EUDA $1.85
  • 52 Week High
  • CDXS $6.08
  • EUDA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 53.65
  • EUDA 54.56
  • Support Level
  • CDXS $2.23
  • EUDA $3.66
  • Resistance Level
  • CDXS $2.59
  • EUDA $3.97
  • Average True Range (ATR)
  • CDXS 0.13
  • EUDA 0.17
  • MACD
  • CDXS 0.05
  • EUDA 0.00
  • Stochastic Oscillator
  • CDXS 81.82
  • EUDA 53.57

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.

Share on Social Networks: